Xencor
XNCR
#5094
Rank
โ‚ฌ1.67 B
Marketcap
22,48ย โ‚ฌ
Share price
-9.76%
Change (1 day)
207.36%
Change (1 year)

EPS for Xencor (XNCR)

EPS in 2026 (TTM): -1,97ย โ‚ฌ

According to Xencor's latest financial reports the company's current EPS (TTM) is -1,98ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -1,07ย โ‚ฌ an increase over its 2024 EPS that were of -3,12ย โ‚ฌ.

EPS history for Xencor from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-1,97ย โ‚ฌ84.2%
2025-1,07ย โ‚ฌ-65.75%
2024-3,12ย โ‚ฌ72.38%
2023-1,81ย โ‚ฌ128.26%
2022-0,79ย โ‚ฌ-164.79%
20211,22ย โ‚ฌ-217.36%
2020-1,04ย โ‚ฌ-346.94%
20190,42ย โ‚ฌ-136.57%
2018-1,16ย โ‚ฌ24.07%
2017-0,93ย โ‚ฌ-283.05%
20160,51ย โ‚ฌ-225.53%
2015-0,41ย โ‚ฌ-10.12%
2014-0,45ย โ‚ฌ-109.91%
20134,55ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
7,53ย โ‚ฌ-481.43%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
1,77ย โ‚ฌ-189.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
12,49ย โ‚ฌ-732.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
3,08ย โ‚ฌ-256.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-3,46ย โ‚ฌ 75.11%๐Ÿ‡บ๐Ÿ‡ธ USA
MacroGenics
MGNX
-1,32ย โ‚ฌ-33.19%๐Ÿ‡บ๐Ÿ‡ธ USA